Form 3/A HAEMONETICS CORP For: Aug 30 Filed by: Miller Laurie A.

September 21, 2021 9:15 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Miller Laurie A.

(Last) (First) (Middle)
125 SUMMER STREET

(Street)
BOSTON MA 02110

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/30/2021
3. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Human Resources
5. If Amendment, Date of Original Filed (Month/Day/Year)
09/09/2021
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,233 (1)
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)   (2) 05/18/2028 Common Stock 1,793 56.57 D  
Non-qualified Stock Option (Right to Buy)   (3) 05/18/2027 Common Stock 1,227 103.37 D  
Non-qualified Stock Option (Right to Buy)   (4) 05/14/2026 Common Stock 1,246 98.03 D  
Non-qualified Stock Option (Right to Buy)   (5) 06/11/2025 Common Stock 1,332 93.52 D  
Explanation of Responses:
1. 2,662 securities are in the form of unvested restricted stock units ("RSUs") issued pursuant to the Issuer's 2005 Long-Term Incentive Compensation Plan (as amended) or 2019 Long-Term Incentive Compensation Plan. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. 1,347 of such RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant, with shares vesting on various dates between May 2022 and May 2025. 1,315 of such RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant, with shares vesting in June 2022 and June 2023.
2. Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
3. Reflects options granted on May 18, 2020 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
4. Reflects options granted on May 14, 2019 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
5. Reflects options granted on June 11, 2018 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Michelle Basil, attorney-in-fact for Ms. Miller 09/21/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings